These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38270345)

  • 1. PRKAG2 gene mutation indicating myocardial hypertrophy and Wolff-Parkinson-White syndrome in a 28-year-old woman.
    Xu Y; Li J; Lan T; Lu M
    Eur Heart J Cardiovasc Imaging; 2024 May; 25(6):e171. PubMed ID: 38270345
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial Atrial Enlargement, Conduction Disorder and Symmetric Cardiac Hypertrophy Are Early Signs of PRKAG2 R302Q.
    Hu J; Tang B; Wang J; Huang K; Wang Y; Lu S; Gowreesunkur HB; Wang Y; Wu D; Mayala HA; Wang ZH
    Curr Med Sci; 2020 Jun; 40(3):486-492. PubMed ID: 32681253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy.
    Gollob MH; Seger JJ; Gollob TN; Tapscott T; Gonzales O; Bachinski L; Roberts R
    Circulation; 2001 Dec; 104(25):3030-3. PubMed ID: 11748095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk of sudden death associated with a PRKAG2-related familial Wolff-Parkinson-White syndrome.
    Zhang LP; Hui B; Gao BR
    J Electrocardiol; 2011; 44(4):483-6. PubMed ID: 20381067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional analysis of a novel PRKAG2 mutation responsible for Chinese PRKAG2 cardiac syndrome reveal an important role of non-CBS domains in regulating the AMPK pathway.
    Zhang BL; Xu RL; Zhang J; Zhao XX; Wu H; Ma LP; Hu JQ; Zhang JL; Ye Z; Zheng X; Qin YW
    J Cardiol; 2013 Oct; 62(4):241-8. PubMed ID: 23778007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Patel VV; Arad M; Moskowitz IP; Maguire CT; Branco D; Seidman JG; Seidman CE; Berul CI
    J Am Coll Cardiol; 2003 Sep; 42(5):942-51. PubMed ID: 12957447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac manifestations of PRKAG2 mutation.
    Banankhah P; Fishbein GA; Dota A; Ardehali R
    BMC Med Genet; 2018 Jan; 19(1):1. PubMed ID: 29298659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transgenic mouse model of ventricular preexcitation and atrioventricular reentrant tachycardia induced by an AMP-activated protein kinase loss-of-function mutation responsible for Wolff-Parkinson-White syndrome.
    Sidhu JS; Rajawat YS; Rami TG; Gollob MH; Wang Z; Yuan R; Marian AJ; DeMayo FJ; Weilbacher D; Taffet GE; Davies JK; Carling D; Khoury DS; Roberts R
    Circulation; 2005 Jan; 111(1):21-9. PubMed ID: 15611370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of G100S mutation in PRKAG2 causes Wolff-Parkinson-White syndrome in zebrafish.
    Zhang BL; Ye Z; Xu RL; You XH; Qin YW; Wu H; Cao J; Zhang JL; Zheng X; Zhao XX
    Clin Genet; 2014 Sep; 86(3):287-91. PubMed ID: 23992123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic analysis of PRKAG2 in sporadic Wolff-Parkinson-White syndrome.
    Vaughan CJ; Hom Y; Okin DA; McDermott DA; Lerman BB; Basson CT
    J Cardiovasc Electrophysiol; 2003 Mar; 14(3):263-8. PubMed ID: 12716108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using exome sequencing to identify the cause of myocardial hypertrophy in a Chinese family.
    Pu T; Guo Q; Cao R; Xu R; Sun K; Chen S
    Mol Med Rep; 2015 Sep; 12(3):3662-3666. PubMed ID: 25997934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel PRKAG2 Variant Manifesting with a Cardiac Arrest in a Child.
    Spentzou G; McGowan R; Hares D; McLeod K
    Pediatr Cardiol; 2020 Apr; 41(4):843-845. PubMed ID: 31720784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome.
    Gollob MH; Green MS; Tang AS; Gollob T; Karibe A; Ali Hassan AS; Ahmad F; Lozado R; Shah G; Fananapazir L; Bachinski LL; Roberts R
    N Engl J Med; 2001 Jun; 344(24):1823-31. PubMed ID: 11407343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Spectrum of PRKAG2 Syndrome.
    Porto AG; Brun F; Severini GM; Losurdo P; Fabris E; Taylor MRG; Mestroni L; Sinagra G
    Circ Arrhythm Electrophysiol; 2016 Jan; 9(1):e003121. PubMed ID: 26729852
    [No Abstract]   [Full Text] [Related]  

  • 15. CRISPR correction of the PRKAG2 gene mutation in the patient's induced pluripotent stem cell-derived cardiomyocytes eliminates electrophysiological and structural abnormalities.
    Ben Jehuda R; Eisen B; Shemer Y; Mekies LN; Szantai A; Reiter I; Cui H; Guan K; Haron-Khun S; Freimark D; Sperling SR; Gherghiceanu M; Arad M; Binah O
    Heart Rhythm; 2018 Feb; 15(2):267-276. PubMed ID: 28917552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudden death associated with a novel H401Q PRKAG2 mutation.
    Albernaz Siqueira MH; Honorato-Sampaio K; Monteiro Dias G; Wilson JR; Yavari A; Brasileiro Filho G; Back Sternick E
    Europace; 2020 Aug; 22(8):1278. PubMed ID: 32215636
    [No Abstract]   [Full Text] [Related]  

  • 17. Wolff-Parkinson-White Syndrome with Ventricular Hypertrophy in a Brazilian Family.
    van der Steld LP; Campuzano O; Pérez-Serra A; Moura de Barros Zamorano M; Sousa Matos S; Brugada R
    Am J Case Rep; 2017 Jul; 18():766-776. PubMed ID: 28690312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the role of gamma2 R531G mutation in AMP-activated protein kinase in cardiac hypertrophy and Wolff-Parkinson-White syndrome.
    Davies JK; Wells DJ; Liu K; Whitrow HR; Daniel TD; Grignani R; Lygate CA; Schneider JE; Noël G; Watkins H; Carling D
    Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1942-51. PubMed ID: 16339829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Pathogenesis of Familial Wolff-Parkinson-White Syndrome.
    Miyamoto L
    J Med Invest; 2018; 65(1.2):1-8. PubMed ID: 29593177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variable primary phenotypic manifestations in a rare familial form of Wolff-Parkinson-White syndrome and hypertrophic cardiomyopathy.
    Müllertz KM; Jensen HK
    Europace; 2016 Mar; 18(3):397. PubMed ID: 26333379
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.